These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014 [TBL] [Abstract][Full Text] [Related]
3. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey. Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M; Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150 [TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcome in women with uterine sarcoma. Denschlag D; Masoud I; Stanimir G; Gilbert L Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484 [TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of 105 cases with uterine sarcoma. Yoney A; Eren B; Eskici S; Salman A; Unsal M Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406 [TBL] [Abstract][Full Text] [Related]
9. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma. Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis. Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401 [TBL] [Abstract][Full Text] [Related]
12. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of uterine sarcoma: a 10-year retrospective single-center study in China. Wang JF; Li C; Yang JY; Wang YL; Ji J Diagn Pathol; 2024 Jul; 19(1):94. PubMed ID: 38970112 [TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma: a clinicopathological study of 93 cases. González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834 [TBL] [Abstract][Full Text] [Related]
15. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563 [TBL] [Abstract][Full Text] [Related]
16. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Benito V; Lubrano A; Arencibia O; Andújar M; Alvarez E; Medina N; Falcón JM; Falcón O Int J Gynaecol Obstet; 2009 Oct; 107(1):44-9. PubMed ID: 19555952 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, pathological reevaluation, surgical management and adjuvant therapy of patients with endometrial stromal tumors. Rothmund R; Hartkopf A; Joachim C; Walter CB; Wallwiener M; Kraemer B; Brucker SY; Staebler A; Taran FA Arch Gynecol Obstet; 2014 Dec; 290(6):1195-200. PubMed ID: 24981048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]